Northwestern Mutual Investment Management Company’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
MC
BG
CCM
Northwestern Mutual Investment Management Company's NKTR Position: Q4 2021 in Review
Northwestern Mutual Investment Management Company sold out of Nektar Therapeutics (NKTR) in Q4 2021, closing a stake of 2,024 shares — an estimated $545K sold.
Northwestern Mutual Investment Management Company first reported a position in NKTR in Q1 2018 and held it in 15 quarters. The position peaked at $3.11M in Q1 2018. 241 funds tracked by Wall St. Rank hold NKTR as of Q4 2021.
- Northwestern Mutual Investment Management Company reported no remaining Nektar Therapeutics position as of Q4 2021 after selling out during the quarter.
- Northwestern Mutual Investment Management Company sold 2,024 Nektar Therapeutics shares in Q4 2021, an estimated $545K.
- Northwestern Mutual Investment Management Company first reported a position in Nektar Therapeutics in Q1 2018 and held it in 15 quarters.
- Northwestern Mutual Investment Management Company's Nektar Therapeutics position peaked at $3.11M in Q1 2018.
- 241 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2021.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q4 2021, filed 3 Feb 2022.